Search results for: 'composites technical insights'
- Did you mean
- composites technician insights
- Related search terms
- Composites Global Market Report 2022 | Global Composites Market
- composites+for+building+sector
- composites+in+automotive
- insights global defense market
- Insights for CISOs: The Transition to Quantum-Safe
-
29 Oct 2013  |  Global  |  Technology Research
Innovations in Smart Pills (Technical Insights)
Technology Advances, Trends and Developments
Smart Pill is a collective term referring to class of new-age medical devices that resemble a conventional medical pill or a capsule. However, unlike medical pills that carry a drug load, smart pills are miniature electronic devices. Smart Pills take advantage of the advances made in microprocessors, light-emitting diode technology, CMOS, energy ef...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Mar 2025  |  Global  |  Technology Research
Innovations in Restorative Dentistry
Advancements in Hybrid Composites, Smart Materials, and Digital Technologies Transforming the Restorative Dentistry Market
Technology is transforming the field of dentistry, driven by continuous advancements in dental materials and 3D printing aimed at improving the appearance, functionality, and durability of dental restorations. Emerging dental materials such as hybrid composites and smart composites, as well as digital technologies, including 3D printing and CAD/CAM...
$4,950.00
Special Price $4,455.00 save 10 %
-
24 Apr 2018  |  North America  |  Market Research
Growth Insights—Real World Evidence Analytics Solutions Market
Innovation and Changing End-user Needs Driving Market Growth
Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...
$3,000.00
Special Price $2,250.00 save 25 %
-
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
28 Sep 2015  |  Global  |  Technology Research
Advanced Techniques and Applications in Optical Imaging (TechVision)
The Very Latest in Optical Imaging
Medical imaging modalities such as X-ray imaging, magnetic resonance imaging, positron emission tomography, and others, have been designed to capture high resolution images through minimally-invasive approaches. However, each of these also suffer from limitations, foremost of which is that they utilize ionizing radiation that is hazardous to the pa...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Sep 2026  |  Global  |  Technology Research
Programmable Epigenome Editing for Disease Reversal
Epigenome editing is building a stronger translational foundation, but its broader adoption will depend on solving delivery, targeting and long-term control
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applications shaping the field. It assesses the competitive...
$4,950.00 -
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00 -
19 Sep 2018  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Sep 2025  |  Global  |  Market Research
Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030
Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery
The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...
$4,950.00